Trial intelligence / Profile preview

Remimazolam vs propofol on early postoperative memory after laparoscopic surgery

ChiCTR2500097649Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of USTC
Start
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in perioperative neurocognitive disorder (2 arms), sponsored by First Affiliated Hospital of USTC. Primary endpoints: Assessment of perioperative memory function, Assessment of perioperative cognitive function and 1 more. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

perioperative neurocognitive disorder

Beyond the preview

Go deeper on ChiCTR2500097649.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500097649.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call